IL57730A0 - Process for isolating hepatitis a-virus - Google Patents

Process for isolating hepatitis a-virus

Info

Publication number
IL57730A0
IL57730A0 IL57730A IL5773079A IL57730A0 IL 57730 A0 IL57730 A0 IL 57730A0 IL 57730 A IL57730 A IL 57730A IL 5773079 A IL5773079 A IL 5773079A IL 57730 A0 IL57730 A0 IL 57730A0
Authority
IL
Israel
Prior art keywords
virus
isolating hepatitis
hepatitis
isolating
Prior art date
Application number
IL57730A
Other languages
English (en)
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of IL57730A0 publication Critical patent/IL57730A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32451—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL57730A 1978-07-06 1979-07-04 Process for isolating hepatitis a-virus IL57730A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782829741 DE2829741A1 (de) 1978-07-06 1978-07-06 Verfahren zur gewinnung des hepatitis a-virus

Publications (1)

Publication Number Publication Date
IL57730A0 true IL57730A0 (en) 1979-11-30

Family

ID=6043726

Family Applications (1)

Application Number Title Priority Date Filing Date
IL57730A IL57730A0 (en) 1978-07-06 1979-07-04 Process for isolating hepatitis a-virus

Country Status (6)

Country Link
US (1) US4275165A (da)
EP (1) EP0007461A1 (da)
JP (1) JPS5515796A (da)
DE (1) DE2829741A1 (da)
DK (1) DK283279A (da)
IL (1) IL57730A0 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP950097A2 (en) 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2398504A1 (fr) * 1977-07-29 1979-02-23 Tours Inst Virologie Culture de virus de l'hepatite a, in vitro. application a la production d'un antigene reactif, d'immunserums specifiques et de vaccins contre l'hepatite a

Also Published As

Publication number Publication date
JPS5515796A (en) 1980-02-04
DE2829741A1 (de) 1980-01-24
US4275165A (en) 1981-06-23
EP0007461A1 (de) 1980-02-06
DK283279A (da) 1980-01-07

Similar Documents

Publication Publication Date Title
YU93179A (en) Process for obtaining 4-deacetyl-vinca-leublastin c-3-carboxhydrazide
JPS54160754A (en) Method
PH19618A (en) Process for preparing -2-pyrrolidone
ZA795368B (en) Decaffeination process
JPS54101716A (en) Mold assembling method
GB2030369B (en) Process timers
YU227679A (en) Process for obtaining n-benzylhaloacetamide deriatives
YU241279A (en) Process for obtaining 2-chlorosulfinyl-azetidine-4-one
IL58995A0 (en) Process for puryfiyng insulin
JPS54112965A (en) Molding method
GB2025991B (en) Photopolymerization process
YU48279A (en) Process for preparing insecticidic and acaricidic compounds
GB1552742A (en) Methyl iscoyanate process
ZA804301B (en) Extraction process
JPS54117566A (en) Molding method
YU86879A (en) Process for obtaining 17-beta-carboxy-5-androstane-3-one
ZA79169B (en) Process for decarburising ferro-manganese
YU41874B (en) Process for obtaining 6-mehoxy-2-acetylnaphthalin oximes
ZA80803B (en) Extraction process
EP0005121A3 (en) Stabilisation process
IL57730A0 (en) Process for isolating hepatitis a-virus
JPS5517533A (en) Vibrationnproof method
JPS5547860A (en) Germmkilling process
GB2049466B (en) Extraction process
JPS5517532A (en) Vibrationnproof method